 |
Home
|
|
Clinical Research Services - Clinical Trial Opportunities
Cardiology
A research study of an investigational drug to evaluate whether it can reduce the risk of developing complications after CABG (coronary artery bypass graft) surgery for patients who have significant coronary artery disease that may be caused by blockage of one or more blood vessels in your heart and which needs to be treated by a CABG surgery as the best choice.
A study to determine the safety and efficacy of a carotid stent system when used in the treatment of carotid artery disease.
Men's Health Studies
A study to determine the safety and effectiveness of an investigational drug in the treatment of BPH (enlarged prostate) in men.
A study of an investigational medication for prostate cancer patients with a rising PSA.
A study of an investigational drug for men with non-metastatic (cancer that has not spread to other areas of the body) hormone-resistant prostate cancer.
Neurology
A research study to determine if a recently FDA approved drug, used as an add-on treatment for patients with partial onset seizures (epilepsy), will lessen the frequency of the patient's seizures and to also gain additional information about how the recently approved drug may be used to treat patients in the future.
A study of an investigational device for Percutaneous Vertebral Augmentation to determine if it is safe and effective in the treatment of painful osteoporotic compression fractures of the spine.
Oncology
A study of an investigational drug to determine if it can reduce the risk of previously diagnosed breast cancer from returning.
Rheumatology
A study of an investigational drug for treatment in patients with psoriatic arthritis.
Women's Health Studies
A study of an investigational drug for treating surgically menopausal women with Hypoactive Sexual Desire Disorder.
A study of an investigational drug for pregnant women who have previously had a preterm birth (when a baby is born before 37 weeks of pregnancy ) to determine if the investigational drug will safely reduce the rate of early delivery.
|
|
|
|
